Showing results (1261-1270 of 1,308) with videos related to
Sort By:
Pageof 131
Nature|April 22, 2015
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivoFadi J Najm, Mayur Madhavan, Anita Zaremba, et al.The Journal of Investigative Dermatology|May 26, 2023
Ataxia Telangiectasia Mutated Signaling Delays Skin Pigmentation upon UV Exposure by Mediating MITF Function toward DNA Repair ModeNadav Elkoshi, Shivang Parikh, Hagar Malcov-Brog, et al.Neurology|April 13, 2012
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson diseaseI H Richard, M P McDermott, R Kurlan, et al.Environmental Research|December 29, 2022
A systematic evidence map for the evaluation of noncancer health effects and exposures to polychlorinated biphenyl mixturesLaura M Carlson, Krista Christensen, Sharon K Sagiv, et al.JAMA Neurology|September 3, 2014
APOE, MAPT, and SNCA genes and cognitive performance in Parkinson diseaseIgnacio F Mata, James B Leverenz, Daniel Weintraub, et al.Cancer Research|January 23, 2016
Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk LocusNicola J Camp, Wei-Yu Lin, Alex Bigelow, et al.Nature|July 6, 2017
Transcription elongation factors represent in vivo cancer dependencies in glioblastomaTyler E Miller, Brian B Liau, Lisa C Wallace, et al.Plos Genetics|August 31, 2011
Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffeeTaye H Hamza, Honglei Chen, Erin M Hill-Burns, et al.Cytometry. Part B, Clinical Cytometry|February 4, 2021
Validation of inducible basophil biomarkers: Time, temperature and transportationTheodore Kim, Jing Yu, Henry Li, et al.Molecular Neurodegeneration|September 25, 2015
The RAB39B p.G192R mutation causes X-linked dominant Parkinson's diseaseIgnacio F Mata, Yongwoo Jang, Chun-Hyung Kim, et al.Pageof 131